Login

Audentes Therapeutics, Inc. 3 SEC Filings

Filed On Filing
31 Oct 2022 Form 3: Audentes Therapeutics, Inc., 10% owner and 1 other · Taysha Gene Therapies, Inc.

Holds 7,266,342 shares of Common Stock

17 Jul 2019 Form 3: Conner Edward R., SVP, Chief Medical Officer

No securities owned

01 Apr 2019 Form 3: Meltz Mark A, SVP, General Counsel

Holds 0 shares of No securities beneficially held

04 Jan 2019 Form 3: Mosbrooker Eric, SVP, Chief Commercial Officer

Holds 300 shares of Common Stock

13 Dec 2017 Form 3: Goldberg Mark Alan, Director

Holds 1,500 shares of Common Stock

13 Jun 2017 Form 3: Jarrett Jennifer, Director

Holds 0 shares of No shares of Common Stock are beneficially held

13 Dec 2016 Form 3: Smith Julie, Director

Holds 0 shares of No shares of Common Stock are beneficially held

19 Jul 2016 Form 3: Woiwode Thomas, Director

Holds 0 shares of No securities beneficially held

19 Jul 2016 Form 3: Versant Ventures IV, Llc, 10% owner and 2 others

Holds 0 shares of No securities beneficially held

19 Jul 2016 Form 3: Squinto Stephen P, Director

Holds 7,474 shares of Common Stock

19 Jul 2016 Form 3: Flynn James E, 10% owner and 5 others
19 Jul 2016 Form 3: Soloway Thomas P, Senior Vice President, CFO

Holds 0 shares of No securities beneficially held

19 Jul 2016 Form 3: Silverstein Jonathan, Director

Holds 224,238 shares of Common Stock

19 Jul 2016 Form 3: Schuetz Thomas J., Director

Holds 89,695 shares of Common Stock

19 Jul 2016 Form 3: Prasad Suyash, Senior VP & Chief Med Officer

Holds 0 shares of No securities beneficially held

19 Jul 2016 Form 3: Patterson Matthew R, Director

Holds 201,814 shares of Common Stock

19 Jul 2016 Form 3: Parmar Kush, Director

Holds 0 shares of No securities beneficially held

19 Jul 2016 Form 3: Orbimed Advisors Llc, Director and 2 others

Holds 224,238 shares of Common Stock

19 Jul 2016 Form 3: Newman Mary, SVP, Regulatory Affairs

Holds 0 shares of No securities beneficially held

19 Jul 2016 Form 3: Nagler David, SVP, HR & Corp. Affairs

Holds 0 shares of No securities beneficially held

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support